For 90 years, we’ve been sharing our passion for innovation worldwide.
Today, UCB is a truly global company with operations in over 40 countries
R&D facilities in the United States and Europe
Over 9,000 employees
As leaders in the creation of biopharmaceutical solutions, the focus at UCB is on severe diseases treated by specialists in multiple therapeutic areas, including:
Neurology
Immunology
Rare Disease
Specializing in immunological disease
The expansion of our capabilities in antibody-based drug discovery has led us to new insights in the treatment of inflammatory autoimmune disorders.
At the heart of our mission is an ongoing commitment to empower specialists with highly innovative treatment options that improve patients' lives.
